Home › Trial NCT03731910
Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE
- Trial IDNCT03731910
- StatusUnknown
- PhaseN/A
- Study typeInterventional
- SponsorSeoul National University Hospital
- Enrollment35
- Start date2018-12-11
- ConditionsHepatocellular Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.